Filing Details
- Accession Number:
- 0001209191-12-027021
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-05-09 13:00:00
- Reporting Period:
- 2012-05-07
- Filing Date:
- 2012-05-09
- Accepted Time:
- 2012-05-09 16:40:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1294596 | Nancy Wysenski | C/O Vertex Pharmaceuticals Incorporated 130 Waverly St Cambridge MA 02139 | Evp, Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-05-07 | 6,797 | $33.82 | 43,191 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2012-05-07 | 12,500 | $39.70 | 55,691 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2012-05-07 | 120,000 | $39.70 | 175,691 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2012-05-07 | 3,398 | $38.80 | 179,089 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-05-07 | 147,695 | $54.50 | 31,394 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2012-05-08 | 9,063 | $33.82 | 40,457 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2012-05-08 | 10,196 | $38.80 | 50,653 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2012-05-08 | 18,750 | $39.70 | 69,403 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-05-08 | 9,063 | $59.19 | 60,340 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-05-08 | 10,196 | $62.08 | 50,144 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-05-08 | 18,750 | $63.52 | 31,394 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option | Disposition | 2012-05-07 | 6,797 | $0.00 | 6,897 | $33.82 |
| Common Stock | Stock Option | Disposition | 2012-05-07 | 12,500 | $0.00 | 12,500 | $39.70 |
| Common Stock | Stock Option | Disposition | 2012-05-07 | 120,000 | $0.00 | 120,000 | $39.70 |
| Common Stock | Stock Option | Disposition | 2012-05-07 | 3,398 | $0.00 | 3,398 | $38.80 |
| Common Stock | Stock Option | Disposition | 2012-05-08 | 9,063 | $0.00 | 9,063 | $33.82 |
| Common Stock | Stock Option | Disposition | 2012-05-08 | 10,196 | $0.00 | 10,196 | $38.80 |
| Common Stock | Stock Option | Disposition | 2012-05-08 | 18,750 | $0.00 | 18,750 | $39.70 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 29,453 | 2010-10-14 | 2020-07-13 | No | 4 | M | Direct |
| 87,500 | 2010-03-09 | 2019-12-08 | No | 4 | M | Direct |
| 180,000 | 2011-05-23 | 2019-12-08 | No | 4 | M | Direct |
| 50,977 | 2011-05-03 | 2021-02-02 | No | 4 | M | Direct |
| 20,390 | 2010-10-14 | 2020-07-13 | No | 4 | M | Direct |
| 40,781 | 2011-05-03 | 2021-02-02 | No | 4 | M | Direct |
| 68,750 | 2010-03-09 | 2019-12-08 | No | 4 | M | Direct |
Footnotes
- Transaction made pursuant to Ms. Wysenski's company approved trading plan under Rule 10b5-1.
Billionaire Hedge Funds
